STOCK TITAN

Fabrinet (FN) SEC Filings, Dec 1-13, 2025

FN NYSE

Fabrinet filings document the company’s operating results, financial condition, governance matters and shareholder actions as a Cayman Islands registrant listed under the FN symbol. Its Form 8-K reports furnish quarterly and annual financial results press releases and also record material governance events, including board appointments, director retirements and executive incentive compensation arrangements.

Proxy materials and annual meeting reports disclose board elections, auditor ratification, advisory executive compensation votes, ordinary-share voting results and meeting procedures. Together, these filings provide formal records of Fabrinet’s manufacturing-services business disclosures, capital and shareholder structure, compensation oversight and public-company governance.

Rhea-AI Summary

Fabrinet director reports new equity award. A member of Fabrinet's Board of Directors reported receiving 417 restricted share units on December 11, 2025 as partial compensation for board service. Each unit represents a contingent right to receive one ordinary share of Fabrinet stock at a price of $0 per share.

The restricted share units will vest on January 1, 2027, as long as the director continues to serve on the board through that date. Following this grant, the director beneficially owns 1,773 ordinary shares directly, reflecting a modest increase in personal alignment with shareholder interests.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Fabrinet reported the results of its 2025 Annual General Meeting of Shareholders held on December 11, 2025. Shareholders representing 34,035,138 ordinary shares, or about 95% of shares entitled to vote, were present in person or by proxy, indicating very high participation.

Shareholders elected Dr. Homa Bahrami and Caroline Dowling as Class I directors for three-year terms. Each nominee received a strong majority of votes cast. Investors also ratified PricewaterhouseCoopers ABAS Ltd. as Fabrinet’s independent registered public accounting firm for the fiscal year ending June 26, 2026, with substantial support.

In addition, shareholders approved, on an advisory basis, the compensation of Fabrinet’s named executive officers, with a clear majority voting in favor. Overall, all three management-supported proposals received shareholder approval.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Fabrinet director reports small share sale

A Fabrinet (FN) director reported selling 500 ordinary shares on 12/05/2025 at a weighted average price of about $482.11 per share. The transaction is coded as a sale and was conducted directly by the reporting person. After this trade, the director beneficially owns 2,684 Fabrinet ordinary shares.

The price range for the sale was between $482.00 and $482.18 per share, and detailed breakdowns of the individual sale prices within this range are available upon request from the company, the reporting person, or Commission staff.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Fabrinet director Thomas F. Kelly reported recent transactions in the company’s ordinary shares. On 12/04/2025, he sold 2,200 ordinary shares at a weighted average price of $464.142 per share, leaving him with 18,789 shares immediately after that sale. The sale price reflects individual trades executed between $464.12 and $464.24 per share. On 12/05/2025, he reported a gift of 25 shares, after which he beneficially owned 18,764 ordinary shares, all held directly. The transactions were disclosed on a Form 4 filed for a single reporting person in his capacity as a director of Fabrinet.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Fabrinet insider files notice to sell ordinary shares under Rule 144. A holder plans to sell 500 ordinary shares through Citigroup Global Markets on the NYSE, with an aggregate market value of $241,000. The filing states that 35,827,210 ordinary shares were outstanding at the time of the notice, providing context for the planned sale.

The seller previously disposed of additional ordinary shares over the past three months, including 479 shares on 09/05/2025 for gross proceeds of $175,314 and 500 shares on 12/04/2025 for gross proceeds of $236,000. The shares to be sold were originally acquired from Fabrinet as restricted stock that vested on 01/02/2023 in exchange for services rendered.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Fabrinet director Darlene S. Knight reported an open-market sale of company stock. On 12/04/2025, she sold 500 ordinary shares of Fabrinet at a price of $472 per share, according to a Form 4 filing. After this transaction, she beneficially owns 3,184 ordinary shares, held in direct ownership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Fabrinet director reports small share disposition

A Fabrinet director reported a transaction involving the company’s ordinary shares. On 12/03/2025, the reporting person disposed of 70 ordinary shares at a reported price of $0 under transaction code "G". Following this transaction, the director beneficially owns 14,131 ordinary shares, held directly. No derivative securities transactions were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

FN filed a notice of proposed sale of restricted shares under Rule 144. The seller plans to sell 2,200 shares of common stock through Morgan Stanley Smith Barney LLC on or around 12/04/2025 on the NYSE. These shares have an aggregate market value of $1,021,111.30 based on the pricing used in the notice, compared with 35,827,210 shares of the issuer’s stock outstanding. The securities were originally acquired on 01/01/2016 as restricted stock vesting under a registered plan in payment for services rendered.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Fabrinet insider plans modest share sale under Rule 144. A holder intends to sell 500 Ordinary Shares of Fabrinet on the NYSE through Citigroup Global Markets, Inc. The shares have an aggregate market value of $236,000 based on the figures disclosed, with 35,827,210 Ordinary Shares shown as outstanding.

The 500 shares were originally acquired from Fabrinet on 01/02/2023 through restricted stock vesting in exchange for services rendered. The approximate sale date indicated is 12/04/2025 and the planned venue is the NYSE.

Over the past three months, Darlene S. Knight has already sold 479 Ordinary Shares of Fabrinet for gross proceeds of $175,314. By signing the notice, the seller represents they are not aware of any undisclosed material adverse information about Fabrinet’s current or prospective operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Fabrinet director reports sale of ordinary shares

A Fabrinet director reported selling 3,500 ordinary shares of the company on 12/01/2025. The transaction was coded as a sale and executed at a weighted average price of $453.747 per share, with individual trade prices ranging from $453.71 to $454.15 per share. After this transaction, the reporting person holds 18,316 Fabrinet ordinary shares, owned directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Fabrinet (FN) SEC filings are available on StockTitan?

StockTitan tracks 96 SEC filings for Fabrinet (FN), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Fabrinet (FN)?

The most recent SEC filing for Fabrinet (FN) was filed on December 13, 2025.